91黑料

  1. Home
  2. Solutions
  3. Outcome Measures
  4. Digital Health Technologies

Digital Health Technologies & Digital Biomarkers

Optimise protocol strategies with fit-for-purpose digital measures

91黑料 supports sponsors in accelerating and improving the assessment, selection and deployment of evidence-backed digital measures in clinical trials. 

Our proprietary Atlas platform provides the most comprehensive insights on AI-powered biomarkers, multi-modal technologies, wearable sensors and other digital health technologies. 

With 18,000+ digital measures gathered from 3,600 connected sensors spanning more than 1,300 medical conditions across 20 therapeutic areas and backed by more than 15,000 pieces of evidence, deploying the Atlas platform early in the trial lifecycle helps de-risk endpoint selection and optimize protocol design, and ensures the prioritisation of patient-centred outcomes. 

The Atlas platform is based on comprehensive data:

  • 19,000+

    digital measures and biomarkers

  • 3,600+

    digital health technologies

  • 1,700

    clinical trials

  • 15,000+

    peer reviewed publications, research papers and conference abstracts

Atlas benefits:

  • De-risk trial deployment with validated, scientifically-backed tools and assessments to capture robust data
  • Optimise protocol strategies throughout the trial lifecycle, increasing likelihood of regulatory approval 
  • Development of patient-centered clinical strategies, reducing participation burden and measuring what matters to patients
  • 4x faster decision making with Atlas compared to using traditional research methods

Media contributions

Healthcare professional reviewing clinical trial insights

mHealth & Wearables insights

Our mHealth & Wearables insights will help you to understand and successfully address the complexities of implementation of wearable devices in trial design, execution and reporting.

Read more

Learn more

Request an Atlas platform demo or arrange a meeting

Already a subscriber?

Login here for access to Atlas

In this section

Connect with us